PolarityTE Inc.
-
Financial
PolarityTE Announces Entry Into a Letter of Intent For Acquisition of the Company
SALT LAKE CITY, Dec. 27, 2022 /PRNewswire/ — PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials (the “Company”), today…
Read More » -
Biologics
PolarityTE™ Announces Application of SkinTE™ on First Patients
SALT LAKE CITY, Dec. 15, 2017 (GLOBE NEWSWIRE) — PolarityTE, Inc. (NASDAQ:COOL) announced that human use of SkinTE™ is underway,…
Read More »